ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives

Frontiers in Molecular Biosciences
Federica SaponaroRiccardo Zucchi

Abstract

Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 protein is ubiquitous across mammalian tissues, prominently in the cardiovascular system, kidney, and intestine. ACE2 expression in the respiratory tract is of particular interest, in light of the discovery that ACE2 serves as the initial cellular target of severe acute respiratory syndrome (SARS)-coronaviruses, including the recent SARS-CoV2, responsible of the COronaVIrus Disease 2019 (COVID-19). Since the onset of the COVID-19 pandemic, an intense effort has been made to elucidate the biochemical determinants of SARS-CoV2-ACE2 interaction. It has been determined that SARS-CoV2 engages with ACE2 through its spike (S) protein, which consists of two subunits: S1, that mediates binding to the host receptor; S2, that induces fusion of the viral envelope with the ...Continue Reading

References

Jun 27, 1989·Biochemistry·M R Ehlers, J F Riordan
Jun 18, 1998·Annals of the New York Academy of Sciences·R E IsaacD Coates
Apr 17, 2001·Trends in Microbiology·B T Cookson, M A Brennan
Jan 30, 2002·The Journal of Biological Chemistry·Chad VickersPeter Tummino
Jun 21, 2002·Nature·Michael A CrackowerJosef M Penninger
Sep 3, 2002·American Journal of Respiratory and Critical Care Medicine·Richard P MarshallGeoffrey J Laurent
Oct 3, 2002·Journal of the American Chemical Society·Natalie A DalesMichael A Patane
Jan 24, 2003·Nature·Ramanathan NateshK Ravi Acharya
Feb 28, 2003·The Journal of Biological Chemistry·Lili HuangRobert C Ladner
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
May 6, 2003·Science·Marco A MarraRachel L Roper
Aug 14, 2003·Genome Biology·James F Riordan
Jan 13, 2004·Biochemical and Biophysical Research Communications·Ponraj PrabakaranDimiter S Dimitrov
Feb 3, 2004·The Journal of Biological Chemistry·Paul TowlerMichael W Pantoliano
Mar 25, 2004·Physiological Genomics·Robson A S SantosMichael Bader
May 21, 2004·BMC Medicine·Andrew B GoulterKenneth L Clark
May 29, 2004·Trends in Pharmacological Sciences·Anthony J TurnerNigel M Hooper
Oct 20, 2004·Hypertension·Matthew J HuentelmanDavid A Ostrov
Nov 13, 2004·The Journal of Pathology·A T LelyG J Navis
Jan 27, 2005·European Heart Journal·Louise M BurrellColin I Johnston
Mar 15, 2005·Current Eye Research·C TikellisM E Cooper
May 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Heike HofmannStefan Pöhlmann
Jul 8, 2005·Nature·Yumiko ImaiJosef M Penninger
Aug 2, 2005·Biochimica Et Biophysica Acta·J L GuyA J Turner
Sep 24, 2005·American Journal of Physiology. Cell Physiology·Patricia E GallagherE Ann Tallant
Nov 24, 2005·Life Sciences·Xudong XieLiu Yanrong
Jan 18, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Justin L GrobeMichael J Katovich
Aug 1, 2006·The Journal of Clinical Investigation·Susan B GurleyThomas M Coffman
Sep 2, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Marc F DoobayEric Lazartigues
Sep 22, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Keiji KubaJosef M Penninger

❮ Previous
Next ❯

Citations

Jan 12, 2021·Expert Review of Clinical Pharmacology·Chiranjib ChakrabortyGovindasamy Agoramoorthy
Feb 14, 2021·Irish Journal of Medical Science·Bengi ArslanBedia Dinc
Jan 16, 2021·Cellular & Molecular Immunology·Victor M Arce, Jose A Costoya
Dec 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sk Sarif HassanAdam M Brufsky
Dec 3, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Loai M SaadahIman A Basheti
Mar 7, 2021·International Journal of Molecular Sciences·Barbara MalinowskaEberhard Schlicker
Mar 16, 2021·Frontiers in Cardiovascular Medicine·Johanna Hol FosseReidunn Edelmann
Apr 2, 2021·Frontiers in Cellular and Infection Microbiology·Mariana Guilger-CasagrandeRenata Lima
Jun 11, 2021·Frontiers in Molecular Biosciences·Sonia Beeckmans, Edilbert Van Driessche

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
immunoprecipitation
acetylation
transgenic
X-ray
xenografts

Clinical Trials Mentioned

NCT04312009
NCT04331574

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

© 2021 Meta ULC. All rights reserved